Literature DB >> 11350666

Association of CD8+ T lymphocyte subsets with the most commonly used markers to monitor HIV type 1 infection in children treated with highly active antiretroviral therapy.

J Navarro1, S Resino, J M Bellón, M L Abad, D Gurbindo, E Fernández-Cruz, M A Muñóz-Fernández .   

Abstract

In contrast to adults, there is no information about children concerning the effects of the new antiretroviral therapy on the chronic activation and expansion of CD8+ T cells. We have investigated the relationship between blood CD8(+) T cell subsets, with percent CD4+ cells (%CD4), percent CD8+ cells (%CD8), and plasma viral load (VL), in 39 vertically HIV-1-infected children receiving highly active antiretroviral therapy (HAART) (mean age, 7.6 years; range, 2-15.6 years). CD8+ subsets were examined by three-color multiparametric flow cytometry, and VL was quantified by standard assays. There was a strong positive correlation between activated CD8+ T cells and VL. An increase in memory and memory-activated CD8+ T cells correlated with increased VL, whereas nonactivated memory cells and CD28+ CD8+ T cells correlated negatively with VL. Naive and effector cells did not correlate with VL, although the CD8+ CD45RA -CD62L- subset correlated with increased VL. Activated CD8(+) T cells did not correlate with %CD4, but an increase in memory-activated and effector CD8+ T cells was associated with lower %CD4. Increased naive CD8+ and CD28 +CD8+ T cells showed a positive correlation with %CD4 and a negative correlation with %CD8. In conclusion, in HIV-1-infected children receiving HAART, the activation of CD8+ T cells is associated with high VL, whereas CD8 +CD28+ and nonactivated CD8+ memory cells are associated with lower viral load. Naive CD8+ and CD28 +CD8+ T cells are associated with an improved immunological status.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11350666     DOI: 10.1089/08892220151126607

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  5 in total

1.  HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy.

Authors:  S Resino; I Galán; A Pérez; J A León; E Seoane; D Gurbindo; M Angeles Muñoz-Fernandez
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

2.  Assessment of CD8 T cell immune activation markers to monitor response to antiretroviral therapy among HIV-1 infected patients in Côte d'Ivoire.

Authors:  P Ondoa; S Koblavi-Dème; M-Y Borget; M L Nolan; J N Nkengasong; L Kestens
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

3.  Characteristics of lymphocyte subsets in HIV-infected, long-term nonprogressor, and healthy Asian children through 12 years of age.

Authors:  Jintanat Ananworanich; Tanakorn Apornpong; Pope Kosalaraksa; Tanyathip Jaimulwong; Rawiwan Hansudewechakul; Chitsanu Pancharoen; Torsak Bunupuradah; Mom Chandara; Thanyawee Puthanakit; Chaiwat Ngampiyasakul; Jurai Wongsawat; Suparat Kanjanavanit; Wicharn Luesomboon; Phennapha Klangsinsirikul; Nicole Ngo-Giang-Huong; Stephen J Kerr; Sasiwimol Ubolyam; Tawan Mengthaisong; Rebecca S Gelman; Kovit Pattanapanyasat; Vonthanak Saphonn; Kiat Ruxrungtham; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2010-12       Impact factor: 10.793

4.  Stimulated proliferative responses in vertically HIV-infected children on HAART correlate with clinical and immunological markers.

Authors:  S Resino; M L Abad; J Navarro; J M Bellón; S Sánchez-Ramón; M Angeles Muñoz-Fernández
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

5.  Changes in cellular immune activation and memory T-cell subsets in HIV-infected Zambian children receiving HAART.

Authors:  Kaitlin Rainwater-Lovett; Hope Nkamba; Mwangelwa Mubiana-Mbewe; Carolyn B Moore; Joseph Margolick; William J Moss
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-15       Impact factor: 3.731

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.